Hepatitis B Therapeutics Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hepatitis B Therapeutics
1.2 Key Market Segments
1.2.1 Hepatitis B Therapeutics Segment by Type
1.2.2 Hepatitis B Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hepatitis B Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Hepatitis B Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hepatitis B Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hepatitis B Therapeutics Market Competitive Landscape
3.1 Global Hepatitis B Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Hepatitis B Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hepatitis B Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hepatitis B Therapeutics Sales Sites, Area Served, Product Type
3.6 Hepatitis B Therapeutics Market Competitive Situation and Trends
3.6.1 Hepatitis B Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hepatitis B Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hepatitis B Therapeutics Industry Chain Analysis
4.1 Hepatitis B Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hepatitis B Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hepatitis B Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis B Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Hepatitis B Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Hepatitis B Therapeutics Price by Type (2019-2024)
7 Hepatitis B Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis B Therapeutics Market Sales by Application (2019-2024)
7.3 Global Hepatitis B Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Hepatitis B Therapeutics Sales Growth Rate by Application (2019-2024)
8 Hepatitis B Therapeutics Market Segmentation by Region
8.1 Global Hepatitis B Therapeutics Sales by Region
8.1.1 Global Hepatitis B Therapeutics Sales by Region
8.1.2 Global Hepatitis B Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Hepatitis B Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hepatitis B Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hepatitis B Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hepatitis B Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hepatitis B Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Hepatitis B Therapeutics Basic Information
9.1.2 GlaxoSmithKline Hepatitis B Therapeutics Product Overview
9.1.3 GlaxoSmithKline Hepatitis B Therapeutics Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Hepatitis B Therapeutics SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Hepatitis B Therapeutics Basic Information
9.2.2 Bristol-Myers Squibb Hepatitis B Therapeutics Product Overview
9.2.3 Bristol-Myers Squibb Hepatitis B Therapeutics Product Market Performance
9.2.4 Bristol-Myers Squibb Business Overview
9.2.5 Bristol-Myers Squibb Hepatitis B Therapeutics SWOT Analysis
9.2.6 Bristol-Myers Squibb Recent Developments
9.3 Novira Therapeutics
9.3.1 Novira Therapeutics Hepatitis B Therapeutics Basic Information
9.3.2 Novira Therapeutics Hepatitis B Therapeutics Product Overview
9.3.3 Novira Therapeutics Hepatitis B Therapeutics Product Market Performance
9.3.4 Novira Therapeutics Hepatitis B Therapeutics SWOT Analysis
9.3.5 Novira Therapeutics Business Overview
9.3.6 Novira Therapeutics Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Hepatitis B Therapeutics Basic Information
9.4.2 Johnson and Johnson Hepatitis B Therapeutics Product Overview
9.4.3 Johnson and Johnson Hepatitis B Therapeutics Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Abivax
9.5.1 Abivax Hepatitis B Therapeutics Basic Information
9.5.2 Abivax Hepatitis B Therapeutics Product Overview
9.5.3 Abivax Hepatitis B Therapeutics Product Market Performance
9.5.4 Abivax Business Overview
9.5.5 Abivax Recent Developments
9.6 F. Hoffmann- La Roche
9.6.1 F. Hoffmann- La Roche Hepatitis B Therapeutics Basic Information
9.6.2 F. Hoffmann- La Roche Hepatitis B Therapeutics Product Overview
9.6.3 F. Hoffmann- La Roche Hepatitis B Therapeutics Product Market Performance
9.6.4 F. Hoffmann- La Roche Business Overview
9.6.5 F. Hoffmann- La Roche Recent Developments
9.7 Novartis
9.7.1 Novartis Hepatitis B Therapeutics Basic Information
9.7.2 Novartis Hepatitis B Therapeutics Product Overview
9.7.3 Novartis Hepatitis B Therapeutics Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Merck
9.8.1 Merck Hepatitis B Therapeutics Basic Information
9.8.2 Merck Hepatitis B Therapeutics Product Overview
9.8.3 Merck Hepatitis B Therapeutics Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
10 Hepatitis B Therapeutics Market Forecast by Region
10.1 Global Hepatitis B Therapeutics Market Size Forecast
10.2 Global Hepatitis B Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hepatitis B Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Hepatitis B Therapeutics Market Size Forecast by Region
10.2.4 South America Hepatitis B Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hepatitis B Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Hepatitis B Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hepatitis B Therapeutics by Type (2025-2030)
11.1.2 Global Hepatitis B Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hepatitis B Therapeutics by Type (2025-2030)
11.2 Global Hepatitis B Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Hepatitis B Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Hepatitis B Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hepatitis B Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Hepatitis B Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hepatitis B Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Therapeutics as of 2022)
Table 10. Global Market Hepatitis B Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hepatitis B Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Hepatitis B Therapeutics Product Type
Table 13. Global Hepatitis B Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hepatitis B Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis B Therapeutics Market Challenges
Table 22. Global Hepatitis B Therapeutics Sales by Type (K Units)
Table 23. Global Hepatitis B Therapeutics Market Size by Type (M USD)
Table 24. Global Hepatitis B Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Hepatitis B Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Hepatitis B Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Hepatitis B Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Hepatitis B Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hepatitis B Therapeutics Sales (K Units) by Application
Table 30. Global Hepatitis B Therapeutics Market Size by Application
Table 31. Global Hepatitis B Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Hepatitis B Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Hepatitis B Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Hepatitis B Therapeutics Market Share by Application (2019-2024)
Table 35. Global Hepatitis B Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Hepatitis B Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Hepatitis B Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Hepatitis B Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hepatitis B Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hepatitis B Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Hepatitis B Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hepatitis B Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. GlaxoSmithKline Hepatitis B Therapeutics Basic Information
Table 44. GlaxoSmithKline Hepatitis B Therapeutics Product Overview
Table 45. GlaxoSmithKline Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Hepatitis B Therapeutics SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Bristol-Myers Squibb Hepatitis B Therapeutics Basic Information
Table 50. Bristol-Myers Squibb Hepatitis B Therapeutics Product Overview
Table 51. Bristol-Myers Squibb Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Hepatitis B Therapeutics SWOT Analysis
Table 54. Bristol-Myers Squibb Recent Developments
Table 55. Novira Therapeutics Hepatitis B Therapeutics Basic Information
Table 56. Novira Therapeutics Hepatitis B Therapeutics Product Overview
Table 57. Novira Therapeutics Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novira Therapeutics Hepatitis B Therapeutics SWOT Analysis
Table 59. Novira Therapeutics Business Overview
Table 60. Novira Therapeutics Recent Developments
Table 61. Johnson and Johnson Hepatitis B Therapeutics Basic Information
Table 62. Johnson and Johnson Hepatitis B Therapeutics Product Overview
Table 63. Johnson and Johnson Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Abivax Hepatitis B Therapeutics Basic Information
Table 67. Abivax Hepatitis B Therapeutics Product Overview
Table 68. Abivax Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Abivax Business Overview
Table 70. Abivax Recent Developments
Table 71. F. Hoffmann- La Roche Hepatitis B Therapeutics Basic Information
Table 72. F. Hoffmann- La Roche Hepatitis B Therapeutics Product Overview
Table 73. F. Hoffmann- La Roche Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. F. Hoffmann- La Roche Business Overview
Table 75. F. Hoffmann- La Roche Recent Developments
Table 76. Novartis Hepatitis B Therapeutics Basic Information
Table 77. Novartis Hepatitis B Therapeutics Product Overview
Table 78. Novartis Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novartis Business Overview
Table 80. Novartis Recent Developments
Table 81. Merck Hepatitis B Therapeutics Basic Information
Table 82. Merck Hepatitis B Therapeutics Product Overview
Table 83. Merck Hepatitis B Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. Global Hepatitis B Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 87. Global Hepatitis B Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Hepatitis B Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 89. North America Hepatitis B Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Hepatitis B Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 91. Europe Hepatitis B Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Hepatitis B Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 93. Asia Pacific Hepatitis B Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Hepatitis B Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 95. South America Hepatitis B Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Hepatitis B Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Hepatitis B Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Hepatitis B Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 99. Global Hepatitis B Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Hepatitis B Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 101. Global Hepatitis B Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 102. Global Hepatitis B Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Hepatitis B Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis B Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Hepatitis B Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Hepatitis B Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis B Therapeutics Market Size by Country (M USD)
Figure 11. Hepatitis B Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Hepatitis B Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Hepatitis B Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hepatitis B Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hepatitis B Therapeutics Market Share by Type
Figure 18. Sales Market Share of Hepatitis B Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Hepatitis B Therapeutics by Type in 2023
Figure 20. Market Size Share of Hepatitis B Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Hepatitis B Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hepatitis B Therapeutics Market Share by Application
Figure 24. Global Hepatitis B Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Hepatitis B Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Hepatitis B Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Hepatitis B Therapeutics Market Share by Application in 2023
Figure 28. Global Hepatitis B Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hepatitis B Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hepatitis B Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hepatitis B Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hepatitis B Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hepatitis B Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hepatitis B Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hepatitis B Therapeutics Sales Market Share by Region in 2023
Figure 44. China Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hepatitis B Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Hepatitis B Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hepatitis B Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hepatitis B Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hepatitis B Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hepatitis B Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hepatitis B Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hepatitis B Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hepatitis B Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Hepatitis B Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Hepatitis B Therapeutics Market Share Forecast by Application (2025-2030)
Industry Market Size
